Mycophenolate Mofetil-Induced Peripheral Neuropathy In The Treatment of
Membranous Glomerulonephropathy: A Case Report
Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used
in the management of Membranous Glomerulonephropathy (MGN). In this
report, we describe a 66-year-old male MGN case treated with MMF and
revealed acquired sensory-motor axonal polyneuropathy, which is rare and
has not been reported before.